PHARMACYTE BIOTECH, INC. Repayments of Related Party Debt
PHARMACYTE BIOTECH, INC. (PMCB) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2016-04-30, per its 10-K filed 2016-07-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2016-07-29
- PHARMACYTE BIOTECH, INC. repayments of related party debt for the quarter ending 2016-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for the quarter ending 2016-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for the quarter ending 2015-10-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for the quarter ending 2015-07-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for fiscal 2015 was $143.86K, a 133.83% increase from fiscal 2014.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for fiscal 2014 was $61.52K, a 17.97% decline from fiscal 2013.
- PHARMACYTE BIOTECH, INC. repayments of related party debt for fiscal 2013 was $75.00K, a 199.94% increase from fiscal 2012.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 3 month as first filed | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 6 month as first filed | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 9 month as first filed | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 | ||||
| 2016-01-31 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-03-08 | $0.00 derived: sum of 2 quarters · filed 2016-03-08 | $0.00 10-Q · filed 2016-03-08 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2015-10-31 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2015-07-31 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $125.14K derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $125.14K derived: sum of 3 quarters · filed 2016-07-29 | $143.86K 10-K · filed 2016-07-29 | ||||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-03-08 | $125.14K derived: sum of 2 quarters · filed 2016-03-08 | $143.86K 10-Q · filed 2016-03-08 | $182.79K derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-10-31 | $125.14K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $143.86K 10-Q/A · filed 2016-01-19 | $182.79K derived: sum of 3 quarters · filed 2016-07-29 | $182.79K derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-07-31 | $18.72K 10-Q/A · filed 2016-01-19 | $57.65K derived: sum of 2 quarters · filed 2016-07-29 | $57.65K derived: sum of 3 quarters · filed 2016-07-29 | $77.64K derived: sum of 4 quarters · filed 2016-07-29 | ||||
| 2014-04-30 | $38.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $38.93K derived: sum of 2 quarters · filed 2016-07-29 | $58.93K derived: sum of 3 quarters · filed 2016-07-29 | $61.52K 10-K · filed 2016-07-29 | ||||
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $20.00K derived: sum of 2 quarters · filed 2015-03-13 | $22.59K 10-Q · filed 2015-03-13 | $97.59K derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-10-31 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $22.59K 10-Q · filed 2014-12-15 | $97.59K derived: sum of 3 quarters · filed 2016-01-19 | $97.59K derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-07-31 | $2.59K 10-Q · filed 2014-09-15 | $77.59K derived: sum of 2 quarters · filed 2016-01-19 | $77.59K derived: sum of 3 quarters · filed 2016-01-19 | $77.59K derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-04-30 | $75.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $75.00K derived: sum of 2 quarters · filed 2016-01-19 | $75.00K derived: sum of 3 quarters · filed 2016-01-19 | $75.00K 10-K/A · filed 2016-01-19 | ||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $8.01K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 | $8.01K derived: sum of 3 quarters · filed 2013-12-16 | $9.01K derived: sum of 4 quarters · filed 2013-12-16 | ||||
| 2012-07-31 | $0.00 10-Q · filed 2013-09-16 | $8.01K derived: sum of 2 quarters · filed 2013-09-16 | $9.01K derived: sum of 3 quarters · filed 2013-09-16 | $16.00K derived: sum of 4 quarters · filed 2013-09-16 | ||||
| 2012-04-30 | $8.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $9.01K derived: sum of 2 quarters · filed 2013-07-29 | $16.00K derived: sum of 3 quarters · filed 2013-07-29 | $25.00K 10-K · filed 2013-07-29 | -$25.00K 10-K · filed 2012-08-14 | |||
| 2012-01-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $8.00K derived: sum of 2 quarters · filed 2013-03-26 | $17.00K 10-Q · filed 2013-03-26 | -$17.00K 10-Q · filed 2012-03-21 | ||||
| 2011-10-31 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | $16.00K 10-Q · filed 2012-12-26 | -$16.00K 10-Q · filed 2011-12-15 | |||||
| 2011-07-31 | $9.00K 10-Q · filed 2012-09-19 | -$9.00K 10-Q/A · filed 2011-09-20 | ||||||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | $0.00 derived: sum of 2 quarters · filed 2012-03-21 | $0.00 10-Q · filed 2012-03-21 | |||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||||||
| 2010-07-31 | $0.00 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |